Advertisement

July 2015 Briefing – Nephrology

0
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for July 2015. This roundup includes the latest...
The American Medical Association is encouraging clinicians to share their perspectives on electronic heath records and the meaningful use program.

AMA Wants Doctor Input on EHRs, Meaningful Use

0
Doctors encouraged to share stories, e-mail Congress members
Tyrosine kinase inhibitors appear to be safe in patients with chronic-phase chronic myeloid leukemia and chronic kidney disease

Tyrosine Kinase Inhibitors Seem Safe in CML With CKD

0
In these patients, no further decline in GFR, regardless of TKI used
From 2014 to 2024

U.S. Health Spending Projected to Rise 5.8 Percent By 2024

0
Increase due to ACA coverage expansions, faster economic growth, population aging
Cranberry juice capsules reduce the rate of urinary tract infection in women undergoing elective benign gynecological surgery involving urinary catheterization

Cranberry Juice Capsules Cut UTI Risk After Gynecological Surgery

0
Findings for women undergoing elective gynecologic surgery involving urinary catheterization
Tamsulosin can boost the passage of large kidney stones

Tamsulosin Could Help Passage of Larger Kidney Stones

0
Especially helpful with larger stones, while smaller ones may pass on their own
Mild hypothermia could improve the functioning of kidneys in transplants from deceased donors

Mild Hypothermia May Boost Kidney Function After Transplant

0
Researchers find mild hypothermia boosts outcomes from deceased donors
The 2015 version of the American Board of Internal Medicine maintenance-of-certification program is expected to generate considerable costs

2015 MOC Program Expected to Cost $5.7 Billion Over 10 Years

0
Time costs account for 90 percent of maintenance of certification costs, estimated at $5.1 billion
Millions more Americans have affordable health insurance

Patients Report Improved Care Access, Better Health With ACA

0
Gains seen in how many adults have insurance and a doctor, and say they are in better health
About 10 percent of cases where a drug does serious harm are not reported to the U.S. Food and Drug Administration within the required 15-day period

Delays Noted in the Reporting of Serious Patient Harms to FDA

0
Analysis found roughly 10 percent of cases were filed after 15-day deadline passed